Clindamycin Phosphate Injection IP

Trade Name: VacClind
Available Strength : 300 mg
Available Combination : Clindamycin Phosphate Injection IP is an antibiotic used to treat serious bacterial infections by inhibiting bacterial protein synthesis.
Packing : 1 x 2 ml Amp.
Pack Insert/Leaflet : YES
Therapeutic use : Clindamycin Phosphate Injection IP is a broad-spectrum antibiotic used to treat serious bacterial infections caused by susceptible anaerobic and aerobic bacteria. It is commonly prescribed for infections of the respiratory tract, skin and soft tissues, bones and joints, and intra-abdominal infections, especially when oral administration is not possible or rapid action is required.
Capacity : 100000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.